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Abstract
Background: Pathology reports are written in free-text form, which precludes efficient data gathering. We aimed to
overcome this limitation and design an automated system for extracting biomarker profiles from accumulated
pathology reports.
Methods: We designed a new data model for representing biomarker knowledge. The automated system parses
immunohistochemistry reports based on a “slide paragraph” unit defined as a set of immunohistochemistry findings
obtained for the same tissue slide. Pathology reports are parsed using context-free grammar for immunohistochemistry,
and using a tree-like structure for surgical pathology. The performance of the approach was validated on manually
annotated pathology reports of 100 randomly selected patients managed at Seoul National University Hospital.
Results: High F-scores were obtained for parsing biomarker name and corresponding test results (0.999 and 0.998,
respectively) from the immunohistochemistry reports, compared to relatively poor performance for parsing surgical
pathology findings. However, applying the proposed approach to our single-center dataset revealed information on 221
unique biomarkers, which represents a richer result than biomarker profiles obtained based on the published literature.
Owing to the data representation model, the proposed approach can associate biomarker profiles extracted from an
immunohistochemistry report with corresponding pathology findings listed in one or more surgical pathology reports.
Term variations are resolved by normalization to corresponding preferred terms determined by expanded dictionary look-
up and text similarity-based search.
Conclusions: Our proposed approach for biomarker data extraction addresses key limitations regarding data
representation and can handle reports prepared in the clinical setting, which often contain incomplete sentences,
typographical errors, and inconsistent formatting.
Keywords: Biomarkers, Cancer disease knowledge representation model, Pathology reports, Natural language
processing, Clinical decision-making
Background
Precision medicine is a newly emerging trend in medi-
cine, whereby individualized medical treatments are
designed based on the specific biologic information of
each patient. Traditionally, tumors are classified based
on their histological features. However, in the era of pre-
cision medicine, the biological behavior is interpreted in
terms of not only histological morphology but also gen-
omic features of the tumor.
For individualized diagnosis, pathologists currently rely
substantially on immunohistochemistry (IHC) findings,
which provide clues regarding genomic features in terms
of relevant biomarkers [1]. Biomarkers reflect the bio-
logic behavior of tumors, including pathogenicity and
pharmacologic response [2, 3]. Thus, to ensure a reliable
histologic diagnosis, it is important to have access to
statistical data from pathology reports regarding similar
patients, which can be achieved through the retrospect-
ive study of relevant reports describing biomarker
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findings, tumor staging, and morphologic features of the
cancer [3–6].
Pathpedia (www.pathpedia.com) [7] is an online re-
source of pathology information providing statistical
data including biomarker levels, anatomical pathology
features, and clinical pathology features. The main ad-
vantages of Pathpedia include high-level, manual cur-
ation of data and the large number of information
sources (up to 4000 references). However, there are dis-
advantages to using journal articles as the main source
of reference data. Specifically, certain biomarkers are
discussed in a limited number of journal articles, which
precludes data verification. Moreover, there is limited
coverage of various ethnic groups and uneven data dis-
tribution regarding race, life patterns, nutritional habits,
geology, and climate, which precludes genomic-level
comparisons based on data from Pathpedia.
The present study focused on the Korean population
and involved careful review of 82,291 pathology reports,
including IHC and surgical pathology (SP) reports, from
Seoul National University Hospital (SNUH). In order to
facilitate the detection of potential relationships between
various immunologic biomarkers and pathologic diagno-
sis, we previously developed a web-based information
system [8] designed to compute and display statistics of
clinical data extracted from pathology reports (e.g., af-
fected organ, diagnosis, cancer staging information, and
IHC findings).
We further describe related work in the field of auto-
mated extraction of data from medical reports, and then
introduce our information extraction approach specific-
ally tailored to pathology reports. We then describe in
detail the result of text processing via our proposed
approach, as well as the relevance of the findings. Fi-
nally, we cover the limitations and implications of our
proposed solution.
Most previous studies on automatic extraction of bio-
marker data focused on biomedical literature [9–11].
Yonesi et al. [9] suggested a system for improved recog-
nition of biomarker names in published literature, which
is implemented in ProMiner [10] and represents a rule-
based system for gene name normalization. The BioNER
[11] system uses a custom-made biomarker-specific dis-
ease dictionary to extract disease-related biomarkers
from MEDLINE publications. However, the performance
of these systems is insufficient for processing pathology
documents because of intrinsic differences between such
clinical documents and published scientific articles. Spe-
cifically, to enhance readability in the clinical setting,
pathology reports generally do not follow formal gram-
mar rules and are instead written in a keyword-oriented
style and formatted using many line breaks, white
spaces, and hyphens. This type of formatting makes it
difficult to automatically detect the sentence boundary
and apply normalization of term variation, which is
particularly relevant because current solutions for bio-
marker data mining employ context to a substantial
extent.
Although some studies have attempted to extract bio-
marker information, these typically focused on extract-
ing cancer-related information (e.g., histologic type and
stage) from pathology reports, and, in particular, from
SP reports. Such studies [12–20] typically apply pattern-
based natural language processing for extracting infor-
mation on specific types of cancer (especially breast or
lung cancer), which is not applicable to mining data on
other types of cancer. On the other hand, Coden et al.
[19] proposed a pan-cancer knowledge representation
model for data from SP documents. Specifically, the
Cancer Disease Knowledge Representation Model
(CDKRM) defines what entities can be extracted and
what relations these entities can have with each other.
However, the CDKRM does not cover IHC findings and
does not define how to combine biomarker information
parsed from IHC reports with corresponding pathologic
findings parsed from SP reports. For the same reason,
the PEP [20] system, which follows the CDKRM for
information extraction, cannot extract biomarker infor-
mation by default and also requires modification to han-
dle keyword-oriented SP reports typically encountered
in clinical practice.
Unlike biomedical literature, clinical reports some-
times contain specific jargons and spelling errors [21],
and therefore the identified medical terms require fur-
ther normalization, i.e., ensuring that clinical terms with
the same meaning are represented in the model using
the same term. The cTAKES approach [22] is well
known for its ability to recognize most medical terms
(including anatomical sites and disease names) from
clinical documents and to correctly normalize these
terms to their Unified Medical Language System
(UMLS) [23] identifiers. However, UMLS does not cover
all variants of biomarker-related terminology used in
IHC. Even though cTAKES can employ other dictionar-
ies than UMLS for normalization, as it was designed to
handle general clinical documents following formal
English grammar, it is difficult to customize cTAKES for
efficient normalization of keyword-based reports such
as IHC.
Methods
Representation of biomarker knowledge
Our data model for representing biomarker knowledge
is similar to the CDKRM [19], but it contains a new
framework for handling IHC reports. Specifically, the
CDKRM covers only microscopic pathologic findings
from SP reports as model entities, whereas the model
developed in the present study can represent biomarker
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test results extracted from IHC reports. Additionally,
our model has the ability to define which biomarker test
described in an IHC report represents evidence for
which microscopic finding described in an SP report,
which helps avoid incorrect assignment of IHC findings
to pathology findings described in the SP report of
another patient or of the same patient but for a different
indication. For example, when the patient shows symp-
toms suggesting metastatic cancer, the physician may con-
duct the same IHC test for several tissue slides obtained
from the same patient (Fig. 1a and b, Additional file 1: Fig-
ure S1a and S1b). The results of such an IHC test may be
Fig. 1 Representation model for information extraction of biomarker. a Reporting system for multi biopsy samples from a patient. As same
biomarker test can be conducted for tissue slide #1 and tissue slide #2 of the patient, a IHC report can contain multiple “slide paragraph (TS_P)”.
Also, multiple pathologic findings derived from multiple IHC tests can be reported in one SP report b) or in separate SP reports. c Representation
model for information extraction of biomarker from pathology reports in Seoul National University Hospital. IHC:immunohistochemistry,
SP:surgical pathologic, BN:biomarker name
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reported either in an addendum to the original IHC and
SP reports (Fig. 1a), or in an entirely new report (Fig. 1b,
Additional file 1: Figure S1a and S1b) [24]. Thus, when de-
signing the data representation model, it is important to
take into account that the patient may have one or more
SP reports with various microscopic findings for different
tissue slides.
To facilitate appropriate association between the find-
ings described in IHC reports and those described in SP
reports, we assumed that a tissue slide represents the
minimum unit for describing a pathologic finding. This
assumption is based on the fact that almost every IHC
report states the serial number of the target tissue slide
at the top of the results of each analysis performed as
the guidelines of College of American Pathologist (CAP)
(Additional file 1: Figure S1c) [25, 26]. Furthermore,
some descriptions of pathologic findings in the SP report
explicitly state which tissue slide provides evidence for
that particular finding. Thus, we associated IHC findings
with microscopic findings based on tissue slide identi-
fiers (TS_IDs), which represent the serial numbers of tis-
sue slides; furthermore, we introduced the tissue slide
paragraph (TS_P) to refer to a set of IHC findings corre-
sponding to a single tissue slide.
Parsing IHC reports using TS_P provides another ad-
vantage for cases where the same IHC tests are repeated
within a certain time interval because previous tests
showed unstable results (Additional file 1: Figure S1a
and S1b). In such situations, the same tissue slide (i.e.,
TS_ID) will show different IHC results, which can be
traced easily by collecting all TS_Ps pointing to the same
TS_ID, and subsequently checking the time stamps.
However, parsing the SP reports according to this
model can be challenging. Most SP reports at SNUH
describe microscopic findings organized by the anatom-
ical site of the tested tissue sample, not by TS_ID which
is consistent with guidelines of CAP (Additional file 2:
Figure S2b and S2c) [24]. Therefore, when the SP report
describes the microscopic findings in tissue samples
from more than two different anatomical sites or in sam-
ples of the same tissue but with distinct pathological
characteristics, it is not appropriate to simply map all
tissue slides to the anatomical site first mentioned in the
SP report. Instead, the system needs to determine the
anatomical site of origin for each tissue slide. Fortu-
nately, since one tissue sample is typically resected from
each anatomical site, the algorithm steps for determining
the anatomical site need to be triggered only when the
SP report mentions more than two anatomical sites,
thereby minimizing the computational burden of this
procedure. A scheme describing our data representation
model is given in Fig. 1c.
Information extraction from IHC reports
SNUH reports adopt a semi-structured style for describ-
ing IHC findings, further classified as list- or table-based
style (Additional file 1: Figure S1a and S1b). We de-
signed the information extraction system in consider-
ation of this semi-structured style, to ensure simplicity
and accuracy of parsing. After collecting a set of patterns
for each style (i.e., list- or table-based) from training set,
we defined a context-free grammar to identify which to-
kens stand for biomarker names (BNs; e.g., p53, p63,
Cyclin-D1) and which tokens represent the correspond-
ing test results (TRs; e.g., positive, negative). The parsing
also takes note of the boundary of each TS_P tagged
with the appropriate TS_ID. Parsing is achieved using
either a list parser or a table parser (Fig. 2), and items
parsed from IHC reports are associated with corre-
sponding microscopic findings parsed from SP reports
based on TS_ID.
Fig. 2 Flow chart of information extraction from IHC report with an example. Step #1) Classify type of IHC report and choose appropriate parser
for the input. Step #2) Normalize biomarker names recognized from step #1 using BN dictionary. Step #3) Normalize test results recognized from
step #1 using TR dictionary. BN: biomarker name, TR: test result
Lee et al. BMC Medical Informatics and Decision Making  (2018) 18:29 Page 4 of 11
Biomarker term normalization handles terminology vari-
ation in BNs and ensures that, for example, ‘Wilms’ tumor
1 protein’, ‘WT-1′, ‘Wilms tumor 1-protein’, and ‘WT1 (4)’
are converted into the single representative form ‘Genes,
Wilms Tumor’. To facilitate term normalization, we created
a BN dictionary for dictionary look-up and text similarity-
based search. The dictionary is based on a list of official
product names of biomarkers used at SNUH, comprising
184 original BNs, which we annotated with Preferred
Terms (P_BN) of Medical Subject Headings (MeSH) codes.
If there was no MeSH entry for a given BN, the P_BN
assigned by the pathologists was used as the general term.
The list of BNs was then automatically expanded with a set
of hand-crafted rules to cover simple variations in notation,
such as addition of hyphens or white spaces. This type of
dictionary expansion was designed to make text similarity-
based searching fast and efficient.
The rules applied to expand the BN dictionary (Table 1)
are similar to those described by Bravo et al. [11] for term
normalization of gene/biomarker protein names in the
biomedical literature, except we remove laboratory-related
terms included in parenthesis, so that ‘WT-1 (4)’ and
‘WT-1 (Repeat)’ are normalized to ‘WT-1’. Consequently,
the number of entries in the expanded BN dictionary was
3370. This BN dictionary was cross-checked by three
pathologists at SNUH.
Term variations in TRs were also considered. For
example, ‘positive in mesothelial cells’ and ‘positive in
tumor cells’ are normalized to ‘Positive’, whereas and
‘focal weak positive’ and ‘a few positive cells’ are
normalized to ‘Focal positive’. Unfortunately, as TR
normalization requires background knowledge about the
tested biomarkers, it was not feasible to create a TR dic-
tionary by applying the same rule-based approach as that
used for creating the BN dictionary. Therefore, three pa-
thologists manually created a TR dictionary based on all
TRs from training set to assign the normalized TR
terms: “Positive”, “Focal Positive”, “Negative”, or “Error”
(i.e., failed IHC test or spelling error that precludes
normalization of the detected TRs). This TR dictionary
was then used for normalization of TR terms by diction-
ary look-up.
Information extraction from SP reports
SP reports are parsed and processed in a similar manner
as that employed for handling IHC reports. However, un-
like IHC reports, SP reports are rather unstructured in
terms of reporting style, and thus, the grammar-based
parsing approach used for parsing IHC reports was not
adequate for parsing SP reports, as it could not account
for all patterns of reporting styles employed in SP reports.
Fortunately, in most SP reports archived at SNUH, the
first few lines typically mention what organ the tissue
sample originated from, whereas the subsequent lines
describe the pathologic findings for that tissue [24]. Add-
itionally, when pathologic findings are reported for a spe-
cific disease, these findings are grouped under the disease
name with an indentation which is consistent with recom-
mendation of CAP for visual separation (Additional file 2:
Figure S2b and S2c) [24]. We took this behavioral ten-
dency into account when designing the parser, aiming to
reduce the search space for each item and improve pars-
ing accuracy. Specifically, we implemented a tree-based
parsing approach of the SP reports, whereby the tree root
node is designated in terms of the organ name. In the
example illustrated in Fig. 3, the organ name “Breast” ap-
pears on the first line of the SP report, so the system cre-
ates a tree with the root node containing the first line.
Because the next line is numbered and starts with the dis-
ease name “1. INFILTRATING DUCT CARCINOMA,
multiple, residual (see note)”, this line is assigned as the
first sub-node of the root node, at the same level as other
numbered lines, such as “2. Fibrocystic change with
microcalcification”. Because the lines below the first sub-
node have indentations, the system assigns them as sub-
nodes of the first sub-node. In this way, the system can
generate candidate boundaries for organs, diseases, and
specific pathologic findings.
In other words, to create a tree with the root node rep-
resented by the organ, the parser must recognize the
organ name correctly. To implement such a parser, we
first created a dictionary based on terms corresponding to
organ names from the Systematized Nomenclature of
Medicine-Clinical Terms (SNOMED-CT). The system
performs a dictionary look-up operation and calculates a
look-up score as the linear sum of the Edit distance, string
kernel, Jaro-Winkler distance, and soft term frequency-
inverse document frequency statistic. If the look-up score
is above a certain threshold, the system registers the term
into the organ terminology database, which consists of a
normalized set of terms describing organs. We used a
training set of SP reports to build the organ terminology
database according to this method, which was then veri-
fied and curated by two clinicians at SNUH. When parsing
the SP reports, the system applies a similar approach to
recognize and normalize disease names with UMLS dis-
order names. If a node corresponding to a disease name is
Table 1 Term expansion rules for biomarker names
Rule Example
1) Replace Roman numbers with the
corresponding Arabic numbers
Factor VIII→ Factor 8
2) Replace Greek symbol with the
corresponding letters
CD79 α→ CD79 alpha
3) Remove laboratory related terms CD10(repeat)→ CD10
4) Generate new variants GAL3 = GAL-3 = GAL 3
5) Convert to lowercase DESMIN→ desmin
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found to have a sub-tree, all its sub-nodes are considered
to represent detailed microscopic findings regarding that
disease. Finally, for recognition of negation and metastasis
terms, we used a set of patterns manually created based
on the same training set of SP reports.
Merging IHC and SP information
Biomarker information extracted from IHC reports and
corresponding microscopic findings extracted from SP
reports are matched according to TS_P and TS_ID.
Datasets and performance evaluation
We obtained 41,772 IHC reports and 40,519 SP reports
archived at SNUH between 2007 and 2012 (Table 2). Sub-
sequently, reports created between 2007 and 2011 were
used as the training data set, whereas later reports were
used as a validation data set. Additionally, in order to
create a gold standard for the evaluation, we randomly se-
lected 400 patients for whom we manually annotated the
reports (508 IHC reports and the corresponding 831 SP
reports) using the BRAT tool [27]. There were three
trained annotators. Each document of patient was anno-
tated by two annotators for normalization of BNs and TRs
along with recognition of boundaries of entity mentions.
Inter-annotator agreement was measured by F-measure
[28]. (Additional file 3: Table S1).
For validation, we selected only those IHC reports
for which the corresponding SP reports described in-
formation regarding only one organ and one diagno-
sis, so as to assess solely the issue of data extraction
itself. The issue of discriminating findings that refer
to multiple organs or diagnoses listed in the SP re-
port will be covered in future work, as this aspect
also involves the processing of SP report data without
corresponding IHC findings (e.g., findings of the gross
examination).
The training data was mainly used to generate patterns
while making hand-crafted rules for parsing. Also, we used
the training set to manually curate the dictionaries for
normalization of BNs and TRs. Validation of information
Table 2 Statistics of SNUH dataset
Type of report 2007 2008 2009 2010 2011 2012 Total
IHC 0 6370 7611 8067 10,889 8830 41,772
SP 160 6338 7507 7893 10,341 8280 40,519
IHC Immunohistochemistry reports, SP Surgical pathology reports
Fig. 3 a Excerpt of a SP report, b corresponding parsing tree of SP report in 3a
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extraction was performed on the gold standard set we
manually made.
Results
The IHC report parser extracts TS_ID, BN, and corre-
sponding TRs. The ability of the parser to recognize the
boundaries of these entities was evaluated by exact
matching, which indicated that the parser recognized
the entity boundaries well, with F-1 scores of 1, 0.998,
and 0.9978 for TS_ID, BN and TR, respectively (Table 3).
After parsing each entity, the system normalized term
variants to a single representative term, which was also
achieved with high performance, namely with F-1 scores
of 0.972 and 0.969 for BN and TR, respectively.
On the other hand, the SP report parser was evaluated
only in terms of term boundary recognition for organ
and diagnosis, as the data set used for training only con-
tained such information. The exact matching test indi-
cated good performance for organ name recognition but
poor performance for diagnosis recognition (Table 3).
Because the boundaries of the disease term showed
some differences between annotators, we also applied
overlap matching to evaluate the performance of the
parser regarding term boundary recognition. Although
the exact matching test results indicated low perform-
ance (F-1 score 0.556), the overlap matching test results
indicated higher performance (F1 score 0.773).
When applying the developed system to all pathology
reports (i.e., including the reports used as a validation
data set), 45,999 TS_Ps were found within 41,765 IHC
reports. The remaining 7 IHC reports could not be
parsed because they did not include TS_ID. Further-
more, 4135 of 45,999 TS_Ps identified were ignored be-
cause their corresponding SP reports were not included
in our target dataset. Within the 41,864 TS_Ps analyzed,
the system recognized 206,534 BNs and successfully nor-
malized 205,759 BNs into 215 P_BNs. Each extracted
BN was associated with a corresponding TR. All but 105
TRs were correctly normalized. Finally, we obtained
205,627 BN-TR pairs.
When applying the system to parse 37,211 SP reports
corresponding to 41,864 TS_Ps extracted from IHC re-
ports (Fig. 4), a total of 5012 SP reports were found to
describe no microscopic diagnosis. Furthermore, only SP
reports mentioning a single organ and a single diagnosis
were retained (21,090 SP reports), within which 21,090
candidates for organ names were recognized. With the
exception of 277 organ name candidates, all other candi-
dates were successfully normalized into 46 representative
organ names. Subsequent parsing of disease names resulted
in 20,758 candidate disease names, of which 68.11% were
successfully normalized. The reason for this relatively lower
success rate of the normalization is likely related to includ-
ing inappropriate candidates of disease names, as well as to
the high term variation for disease names. The process of
parsing SP reports is illustrated in Fig. 4, with the main
graph showing statistics for total BNs, and the corner graph
showing statistics for total SP reports.
Finally, we compared the statistics provided by our
proposed approach for information extraction with the
statistics provided by Pathpedia (Fig. 5) regarding the
positive rate of biomarker assays. The first important
difference between the SNUH- and Pathpedia-based
findings is the composition of the set of biomarkers
employed for such analyses. For example, the mean
number of assay attempts for ErbB-2, thymidylate synthase,
EGFR, p53, FOXP3, PDPN, MLH-1, ERCC1, CDH17,
CD44, CK 7, and CK 20 is 469 based on SNUH data, com-
pared to only 132 based on Pathpedia data. Moreover, al-
though the number of ErbB-2 assays was similar (720 and
650 assays for SNUH and Pathpedia, respectively), the rate
of positives (including focal positive) was substantially dif-
ferent, with 290/720 for SNUH and 26/650 for Pathpedia.
Discussion
The proposed approach for automated extraction of bio-
marker data showed high performance for parsing IHC
reports (very high F1-scores), which is due to the very
stable reporting format used at SNUH. Specifically, since
2008, SNUH pathologists have written IHC reports
using one of only two reporting formats (i.e., list- or
table-based). Although there were spelling errors in writ-
ing, detecting certain formatting determinants such as
semi-colon (“;”), colon (“:”), or vertical bar (“|”) was ex-
tremely helpful in accounting for report format varia-
tions while still using relatively simple grammar; in fact,
we were able to update the internal database of IHC re-
port templates with a new version.
Table 3 Extraction performance for IHC and SP
A Recognition Normalization
Recall Precision F1 Recall Precision F1
TS_ID 1 1 1 – – –
BN 0.999 1 0.999 1.000 0.946 0.972
TR 0.998 0.998 0.998 1.000 0.939 0.969
B Exact Matching
Recall Precision F1
Organ 0.896 0.953 0.924
Diagnosis 0.794 0.427 0.556
C Overlap matching
Recall Precision F1
Organ 0.901 0.961 0.930
Diagnosis 0.794 0.754 0.773
TS_ID Tissue slide ID, BN Biomarker name, TR Test result
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Fig. 5 Comparison of the statistics provided by our proposed approach for information extraction with the statistics provided by Pathpedia
regarding the positive rate of biomarker assays. a statistics provided by Pathpedia, b the statistics provided by our proposed approach for
adenocarcinoma, diffuse type and intestinal type in stomach
Fig. 4 The process of parsing SP reports; the main graph showing statistics for total BNs, and the corner graph showing statistics for total SP reports
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Our approach involves using dictionaries for recogniz-
ing and normalizing BNs and TRs, which we created
based on initial processing of the training data set. As
depicted in Fig. 6, a similar number of new IHC tests
(described as BN-TR pairs) were performed each year at
SNUH, and the number of BN terms increased steadily
every year. This finding is related to the fact that, every
year, SNUH purchased a new type of biomarker. More-
over, SNUH received and archived IHC reports prepared
by pathologists at other hospitals regarding patients re-
ferred to SNUH for consultation. Fortunately, most vari-
ations were covered by the expanded BN dictionary, but
terms related to the new biomarkers had to undergo
normalization according to UMLS terminology. Notably,
there was substantially higher variation in TR termin-
ology, and the parser required almost ten times longer
to recognize and normalize TRs than to do so for BNs.
Moreover, as some BNs have numeric TRs whose ranges
may differ with cell type, classifying the TRs into four
categories (positive, focal positive, negative, and error)
resulted in some controversy between consulting
pathologists.
Unlike IHC reports, SP reports at SNUH showed high
variability in reporting style and format, and creating the
SP report parsing tree with a single organ root node was
sometimes difficult because some SP reports contained a
description of findings of the macroscopic or frozen sec-
tion evaluations, which are commonly performed during
surgery. When pathologists deem that further tests are
necessary or they lack sufficient evidence for a definite
diagnosis, they report several candidate disease names.
As the goal of extracting IHC and SP data in this man-
ner is to facilitate detection of potential relationships be-
tween IHC profiles and pathologic diagnosis, further
study is warranted to develop an automated framework
for discriminating between final and intermediate diag-
nosis. Here, we chose to include in the validation data
set only SP reports describing a single sample with a sin-
gle, explicitly stated diagnosis.
Parsing the SP reports produced the name of the
organ of origin of the tissue sample, and the diagnosis
based on microscopic findings. Under the assumption
that the pathologic findings are described after the organ
is mentioned, we could discriminate the lines describing
the organ of origin from the lines describing the disease,
as well as from the lines describing the actual findings,
and organized this information into a tree-like structure.
We then used dictionaries based on SNOMED-CT and
UMLS to further normalize the recognized organ names
and disease names, but these dictionaries did not cover
all parts of the disease or organ names. For example, be-
cause UMLS had an entry only for “gastric carcinoma”,
whereas the SP report was found to refer to “multiple
gastric carcinoma” or “early gastric carcinoma”, we nor-
malized both disease terms to the same identifier. By re-
cording the entire line containing the disease name (part
of which likely corresponds to at least one UMLS term),
we aimed to preserve as much information as possible.
Because we have parsed IHC and SP reports based on
assumptions that may apply only to reports from SNUH,
Fig. 6 The creation rate of new BN term variants per year. Although a similar number of new IHC tests (described as BN-TR pairs) were performed
each year at SNUH, the number of new biomarker name (BN) variants increased steadily every year. This increase is partially related to the increase
of a new type of biomarkers (described as P_BN) which SNUH analyzes
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our approach may not be as easily applied to other hos-
pital data. As we checked two branch hospitals of SNUH
which operate independent hospital information system,
both of which adopt the closely matched reporting for-
mat with SNUH. It is likely that this result comes from a
policy that adheres to guidelines of CAP that recom-
mend to display multiple diagnostic findings with visual
separation such as an indentation for indicating a subor-
dinate relationship or (checklist item: response) style
[24]. Thus, if a hospital is referring to guidelines of CAP,
the representation model we propose would be reason-
able choice when localization efforts for rule-based pars-
ing such as adjusting formatting determinants for visual
separation could be made.
In this study, we proposed a representation model and
developed the system from scratch to apply the model
for information extraction of SNUH pathology reports.
Although our parsing approach is not remarkably in-
novative, we could get data that reveals the differences
between the Korean population and the other ethnic
group of literature, as we defined the entity-relationship
model for reliable associations between IHC results and
microscopic findings and developed a systematic strat-
egy. Also, in addition to that the web-based information
system which calculates multi-conditional statistics of
the extracted data from this study showed stable per-
formance, 25 pathologists confirmed that the statistics is
reliable in the previous study [8]. Accordingly, we could
say that our representation model is reasonable for pre-
senting the entities for pathology reports.
Conclusion
We proposed a systematic approach to mine and corrob-
orate biomarker information from IHC reports and SP
reports. According to our new data representation
model for biomarker knowledge from pathology records,
IHC reports are parsed using a grammar-based ap-
proach, whereas the corresponding SP reports are parsed
using a tree-based approach. Term variations are re-
solved by normalization to corresponding preferred
terms determined by expanded dictionary look-up and
text similarity-based search. Finally, IHC data and rele-
vant pathological findings are associated with corre-
sponding clinical information from SP reports based on
TS_ID and TS_P. When tested on a manually annotated
dataset, acceptable F-scores were obtained for parsing
(with term recognition and normalization) of both IHC
reports and SP reports. We applied the developed ap-
proach to process 41,772 IHC reports and 40,519 SP re-
ports archived between 2007 and 2012 at SNUH, and
obtained information on 221 unique biomarkers, which
is consistent with biomarker profiles obtained from the
literature but provides more comprehensive statistics re-
garding biomarker use.
Additional files
Additional file 1: Figure S1. a) list-style of IHC report of a patient, b)
table-style of IHC report of the same patient reported later in a separate
document, c) excerpt of synoptic report template from College of American
Pathologists (CAP) which shows that tissue block number should be de-
scribed on the IHC report. (TIF 898 kb)
Additional file 2: Figure S2. Comparison of SP report styles between
SNUH and report templates from CAP. a) SP report at SNUH which shows
the combination of synoptic report style and non-synoptic report style. b)
synoptic report template for ductal carcinoma in situ of the breast which
presents organ information on the first line and describes microscopic
findings in the following lines. The synoptic report template shows the
grouping of pathologic findings using indentation for better visual
separation. c) non-synoptic report template provided by CAP. The first
line contains organ information and the second line contains the
diagnosis information with indentation for visual separation. (TIF 985 kb)
Additional file 3: Table S1. Inter-Annotator Agreement (IAA) for gold
standard set. (XLSX 8 kb)
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